Iconovo won the Lund University Innovation Award. The winning project was “ICOone for inhaled vaccines”. Vaccines are currently administered as injections, which in addition to the associated discomfort also presents a variety of other challenges. One major problem with needles is that they are dangerous to use and can spread infections if not properly handled after use. Another concern is that vaccines for injection must be refrigerated, which is costly and large quantities of vaccine may need to be discarded as a result. Iconovo’s technology solves such problems since the shelf life of inhaled dry powder at room temperature is several months and the inhaler is completely harmless during and after use.